Seeing Is Believing
Currently out of the existing stock ratings of Edwin Zhang, 7 are a BUY (100%).
Analyst Edwin Zhang, carries an average stock price target met ratio of 33.33% that have a potential upside of 27.5% achieved within 96 days. Previously, Edwin Zhang worked at HC WAINWRIGHT.
Edwin Zhang’s has documented 13 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CALT, Calliditas Therapeutics at 27-Dec-2021.
Analyst best performing recommendations are on LMNL (LIMINAL BIOSCIENCES).
The best stock recommendation documented was for LMNL (LIMINAL BIOSCIENCES) at 2/18/2021. The price target of $11 was fulfilled within 288 days with a profit of $51.9 (82.51%) receiving and performance score of 2.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Feb-2021
$11
5 years 3 months 17 days ago
(24-Jun-2021)
1/1 (100%)
$-51.9 (-82.51%)
288
Buy Since 21-Dec-2020
$45
$36.5 (429.41%)
$22
5 years 4 months 9 days ago
(02-Jun-2021)
2/2 (100%)
$1.6 (3.69%)
123